The publications listed here represent a wide range of HaemSTAR involvement, from simple assistance with advertising of the project (e.g. VTE management survey) to original projects devised and conducted by HaemSTAR (e.g. flashmob audits).
Where full manuscripts have been published, conference abstracts are not displayed.
2023
Paper. Re-evaluation of the risk of venous thromboembolism after COVID-19 vaccination using haematological criteria. Click here to view the paper.
Abstract. RAPIDO: Preliminary results from a UK-wide audit of reversal agents for direct oral anticoagulant associated bleeding. Annual Scientific Meeting of the British Society of Haematology, 2023. Click here to view the abstract, and here for the poster.
Abstract. The ‘two sample rule’ in emergency departments: A UK-wide survey of junior doctors/physician associates. British Society of Haematology ASM 2023. Click here for the abstract
2022
Paper. HaemSTAR—Growing Experience From a National, Trainee-led Research Network. HemaSphere, September 2022 Click here
Paper. Diagnostic uncertainty presented barriers to the timely management of acute thrombotic thrombocytopenic purpura in the United Kingdom between 2014 and 2019 Journal of Thrombosis and Haemostasis, February 2022. Click here
Abstract. Anticoagulation Practice, Recurrent Thrombosis, and Major Bleeding in Antiphospholipid Syndrome- a Multicentre Observational Study in the United Kingdom, Oral presentation, American Society of Haematology, December 2023. Click here for the abstract
Paper. Platelet transfusion and anticoagulation in hematological cancer-associated thrombosis and thrombocytopenia: The CAVEaT multicenter prospective cohort. Journal of Thrombosis and Haemostasis, May 2022. Click here
2021
Paper. Therapeutic Anticoagulation in Critically Ill Patients with Covid-19 – The REMAP-CAP, ACTIV-4a & ATTACC Investigators. New England Journal of Medicine, 2021. Click here
Paper. An assessment of the management of anaemia in acute care settings in the United Kingdom: The value of a collaborative approach. Transfusion Medicine, 2021. Click here
Paper. Mycophenolate Mofetil for First-Line Treatment of Immune Thrombocytopenia. New England Journal of Medicine, September 2021. Click here
Paper. The negative impact of the COVID-19 pandemic on UK haematology registrars’ well-being and training: Results of a UK nationwide survey. eJHaem, August 2021 Click here
Paper. Clinical outcomes and the impact of prior oral anticoagulant use in patients with coronavirus disease 2019 admitted to hospitals in the UK – a multicentre observational study. British Journal of Haematology, June 2021. Click here
Paper. The clinical course of CVOID-19 in pregnant versus non-pregnant women requiring hospitalisation: results from the multicentre UK CA-COVID-19 study. British Journal of Haematology, September 2021. Click here
Paper. A single 1 g/kg dose of intravenous immunoglobulin is a safe and effective treatment for immune thrombocytopenia; results of the first HaemSTAR ‘Flash-Mob’ retrospective study incorporating 961 patients. British Journal of Haematology, December 2021. Click here
This was among one of the journal’s most downloaded papers in 2021.
2020
Paper. An international survey of clinicians regarding their management of venous thromboembolism following the initial 3-6 months of anticoagulation. Journal of Thrombosis and Thrombolysis (2020). June 2020. Click here
Abstract. EHA EP1111: Outcomes of 99 patients with myeloproliferative neoplasm (MPN) associated splanchnic vein thrombosis (SVT): First report from the UK MASCOT registry. EHA Library. June 2020. Click here for the abstract
2019
Abstract. Real world effectiveness of thrombopoietin receptor agonists (TRAs) in the management of immune thrombocytopenia (ITP) in the UK: results from a post hoc analysis of the TRAIT study. British Society of Haematology ASM 2019. Click here for the abstract
Paper. A HaemSTAR is born; a trainee-led, UK-wide research network in haematology. Clin Med, November 2019. Click here